BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23465851)

  • 1. Use of magnesium sulfate for treatment of pre-eclampsia and eclampsia in Mexico.
    van Dijk MG; Díaz Olavarrieta C; Zuñiga PU; Gordillo RL; Gutiérrez ME; García SG
    Int J Gynaecol Obstet; 2013 May; 121(2):110-4. PubMed ID: 23465851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating patients with severe preeclampsia and eclampsia in Oaxaca, Mexico.
    Van Dijk MG; García-Rojas M; Contreras X; Krumholz A; García SG; Díaz-Olavarrieta C
    Salud Publica Mex; 2014; 56(5):426-7. PubMed ID: 25604285
    [No Abstract]   [Full Text] [Related]  

  • 3. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia.
    Berhan Y; Berhan A
    J Obstet Gynaecol Res; 2015 Jun; 41(6):831-42. PubMed ID: 25833188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.
    Beyuo T; Lawrence E; Langen ES; Oppong SA
    BMJ Open; 2019 Oct; 9(10):e032799. PubMed ID: 31641005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
    Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate.
    Belfort MA; Clark SL; Sibai B
    Obstet Gynecol Surv; 2006 Oct; 61(10):655-65. PubMed ID: 16978425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals.
    Barua A; Mundle S; Bracken H; Easterling T; Winikoff B
    Int J Gynaecol Obstet; 2011 Dec; 115(3):231-4. PubMed ID: 21930268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period.
    Vigil-De Gracia P; Ludmir J
    J Matern Fetal Neonatal Med; 2015; 28(18):2207-9. PubMed ID: 25373431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be.
    Lumbiganon P; Gülmezoglu AM; Piaggio G; Langer A; Grimshaw J
    Bull World Health Organ; 2007 Oct; 85(10):763-7. PubMed ID: 18038057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
    Tukur J
    Ann Afr Med; 2009; 8(2):76-80. PubMed ID: 19805935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of magnesium sulfate in pre-eclampsia and eclampsia in teaching hospitals in Addis Ababa: a practice audit.
    Getaneh W; Kumbi S
    Ethiop Med J; 2010 Apr; 48(2):157-64. PubMed ID: 20608019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose magnesium sulfate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia.
    Malapaka SV; Ballal PK
    Int J Gynaecol Obstet; 2011 Oct; 115(1):70-2. PubMed ID: 21798536
    [No Abstract]   [Full Text] [Related]  

  • 13. Early standardized treatment of critical blood pressure elevations is associated with a reduction in eclampsia and severe maternal morbidity.
    Shields LE; Wiesner S; Klein C; Pelletreau B; Hedriana HL
    Am J Obstet Gynecol; 2017 Apr; 216(4):415.e1-415.e5. PubMed ID: 28153655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of magnesium sulfate to manage pre-eclampsia and eclampsia in Nigeria: overcoming the odds.
    Ekele BA
    Ann Afr Med; 2009; 8(2):73-5. PubMed ID: 19805934
    [No Abstract]   [Full Text] [Related]  

  • 15. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.
    Aaserud M; Lewin S; Innvaer S; Paulsen EJ; Dahlgren AT; Trommald M; Duley L; Zwarenstein M; Oxman AD
    BMC Health Serv Res; 2005 Nov; 5():68. PubMed ID: 16262902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures in pregnancy/eclampsia.
    Stead LG
    Emerg Med Clin North Am; 2011 Feb; 29(1):109-16. PubMed ID: 21109107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnesium sulfate in obstetrics: current data].
    Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.
    McDonald SD; Lutsiv O; Dzaja N; Duley L
    Int J Gynaecol Obstet; 2012 Aug; 118(2):90-6. PubMed ID: 22703834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
    Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
    Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.
    Katageri G; Charantimath U; Joshi A; Vidler M; Ramadurg U; Sharma S; Bannale S; Payne BA; Rakaraddi S; Karadiguddi C; Mungarwadi G; Kavi A; Sawchuck D; Derman R; Goudar S; Mallapur A; Bellad M; Magee LA; Qureshi R; von Dadelszen P;
    Reprod Health; 2018 Jun; 15(Suppl 1):91. PubMed ID: 29945665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.